Back
MiMedx Group 10K Form
Sell
46
MDXG
MiMedx Group
Last Price:
7.30
Seasonality Move:
21.85%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive MDXG News And Ratings
See the #1 stock for the next 7 days that we like better than MDXG
MDXG Financial Statistics
Sales & Book Value
| Annual Sales: | $321.48M |
|---|---|
| Cash Flow: | $9.78M |
| Price / Cash Flow: | 36.7 |
| Annual Sales: | $0.98 |
| Price / Book: | 7.54 |
Profitability
| EPS (TTM): | 0.38000 |
|---|---|
| Net Income (TTM): | $67.44M |
| Gross Margin: | $266.84M |
| Return on Equity: | 353.28% |
| Return on Assets: | 35.72% |
MiMedx Group Earnings Forecast
Key MiMedx Group Financial Ratios
- The Gross Profit Margin over the past 17 years for MDXG is 83.01%.
- The Selling, General & Administrative Expenses for MDXG have been equal to 65.67% of Gross Profit Margin.
- The Research & Development expenses have been 3.94% of Revenue.
- The Interest Expense is 9.57% of Operating Income.
- The Net Earning history of MDXG is 20.98% of Total Revenues.
- Per Share Earnings over the last 18 years have been positive in 11 years.
MiMedx Group Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | MDXG |
| CUSIP: | 602496 |
| Website: | mimedx.com |
Debt
| Debt-to-Equity Ratio: | 0.34 |
|---|---|
| Current Ratio: | 3.57 |
| Quick Ratio: | 2.95 |
Price-to-Earnings
| Trailing P/E Ratio: | 19.7 |
|---|---|
| Forward P/E Ratio: | 18.46 |
MDXG Technical Analysis vs Fundamental Analysis
Sell
46
MiMedx Group (MDXG)
is a Sell
Is MiMedx Group a Buy or a Sell?
-
MiMedx Group stock is rated a Sell
The current MiMedx Group [MDXG] share price is $7.29. The Score for MDXG is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.